Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-5.41M.
ENTERPRISE VALUE (EV)
$-5.41M
Silexion Therapeutics Ltd.
Market Cap
$109735.00
Enterprise Value (EV)
$-5.41M
Market Cap
$30263.00
Enterprise Value (EV)
N/A
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Silexion Therapeutics Ltd. (SLXN) | $109735.00 | $-5.41M |
| Psyence Biomedical Ltd. (PBM)vs › | $95097.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | N/A |
| Akanda Corp. (AKAN)vs › | $63276.00 | $17.88M |
| Zhongchao Inc. (ZCMD)vs › | $30924.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30263.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $5976.00 | $4.11M |
| SciSparc Ltd. (SPRC)vs › | $245237.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | $371977.00 |
Market Cap
$109735.00
Total Debt
$468000.00
Cash
$5.99M
Enterprise Value
$-5.41M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
